Buy Spravato Online

Spravato (esketamine nasal spray) is a groundbreaking, FDA-approved treatment specifically developed for adults who have not found relief from traditional antidepressants. It is the first and only nasal spray of its kind approved for treatment-resistant depression (TRD) and for major depressive disorder (MDD) with acute suicidal ideation or behavior. Unlike conventional antidepressants that can take weeks to start working, Spravato offers rapid relief. Many patients experience noticeable improvements in mood, motivation, and outlook within 24 to 72 hours after the first dose. It is used in combination with an oral antidepressant and is administered under direct medical supervision in a certified healthcare setting.

Spravato(esketamine) has become the first standalone therapy to be cleared by the US regulator for adult patients with treatment resistant depression (TRD), extending its 2019 approval for use in combination with other antidepressant drugs. Since, Spravato has also been given the go ahead for use in people with major depressive disorder (MDD) who have suicidal thoughts or behaviors.

The new labelling gives a new option to patients who are failing to get relief from depression despite trying multiple treatment regimens, or who are struggling to tolerate them, and could allow Esketamine to be used earlier in the treatment pathway.

Key Uses

• Treatment Resistant Depression: For individuals who have tried at least two different antidepressants without adequate improvement.
• Depression with Suicidal Thoughts: Provides fast-acting relief during a mental health crisis, helping to reduce suicidal ideation quickly.
• Ongoing Maintenance: Helps sustain remission and improve overall quality of life for those struggling with persistent depressive symptoms.

Standard Treatment Schedule

Advisable to start with 56 mg on Day 1, then may increase to 84 mg based on your response and tolerability.

For MDD with acute suicidal ideation, treatment usually starts at 84 mg twice weekly for 4 weeks.

How Spravato Works

Spravato targets the brain’s glutamate system in a unique way. It acts as an NMDA receptor antagonist, rapidly increasing glutamate activity. This triggers a cascade of events that promote neuroplasticity — the brain’s ability to form new neural connections. The result is faster restoration of healthy brain function compared to traditional medications that mainly target serotonin.Why Many Patients Choose Spravato

• Rapid onset of action (often within days instead of weeks)
• Clinically proven to reduce depressive symptoms in patients who previously had little success
• Can significantly improve energy, sleep, appetite, and emotional well-being
• Offers new hope for those who feel they have “tried everything”

Treatment Experience: Each session involves self administering the nasal spray(typically 2–3 sprays per nostril). You remain under observation for at least 2 hours afterward to monitor for temporary side effects such as dissociation, dizziness, or changes in blood pressure. Treatment usually begins with twice-weekly sessions, then tapers to once weekly or less as your symptoms improve.

Spravato Side Effects

(Usually Temporary)

• Dissociation (feeling detached or “out of body”)
• Dizziness, sedation, or vertigo
• Increased blood pressure
• Nausea
• Metallic taste

These effects usually peak within the first hour and mostly resolve within 2 hours.

Why Many Patients Choose Spravato

• Rapid onset of action (often within days instead of weeks)
• Clinically proven to reduce depressive symptoms in patients who previously had little success
• Can significantly improve energy, sleep, appetite, and emotional well-being
• Offers new hope for those who feel they have “tried everything”.

Spravato nasal Spray | Spravato treatment near me | Spravato medication | Spravato for anxiety | Spravato side effects | Esketamine | Spravato side effects